Drug details

Asceniv (immune globulin intravenous, human - slra for injection)

type of Immune Globulins

Asceniv (immune globulin intravenous, human – slra) is a 10% immune globulin liquid for intravenous injection, indicated for the treatment of primary humoral immunodeficiency (PI) in adults and adolescents (12 to 17 years of age).

This drug may have the following side effects:

• nausea,
• diarrhea,
• headache,
• itching
• runny or stuffy nose,
• nosebleed,
• fatigue,
• upper respiratory tract infection,
• sinusitis,
• viral gastroenteritis,
• bronchitis,
• muscle spasms or pain,
• mouth and throat pain,
• pain in extremities, and

The following drugs are related to Asceniv, either as a replacement or used together:

• Bivigam (immune globulin intravenous (human), 10%)
• Panzyga (immune globulin intravenous, human - ifas liquid preparation)
• Xembify (immune globulin subcutaneous, human – klhw injection)